James Basilion, 1984, BA in Biochemistry, University of Pennsylvania. 1990, PhD, Biomedical Science, University of TX, Houston

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Financial Stake
    Ineligible company:
    Akrotome Imaging
    Topic:
    Molecular Imaging
    Date added:
    12/15/2025
    Date updated:
    12/15/2025
  • Attribution:
    Self
    Type of financial relationship:
    Financial Stake
    Ineligible company:
    Vergent Biosciences
    Topic:
    Molecular Imaging
    Date added:
    12/15/2025
    Date updated:
    12/15/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Telix Pharmaceuticals
    Topic:
    Molecular Imaging
    Date added:
    12/15/2025
    Date updated:
    12/15/2025
Return to 157 Radiology/AIRC Research Grand Rounds: “Imaging and Theranostic Agents for Enhanced Outcomes in Cancer" (010826)

 

**Disclaimer**

This Continuing Medical Education (CME) Learning Management System, Ethos, includes individuals designated as 'faculty' for CME purposes. Please note that the term 'faculty' refers solely to their role as a contributor/planner within a CME activity and does not imply any formal affiliation with UT Southwestern Medical Center (UTSW). The display of names and credentials is intended for educational purposes only and does not necessarily indicate a professional or academic relationship with UTSW. Participants are encouraged to verify the affiliations and credentials of faculty members independently if further clarification is needed.